The protein MAST4, a member of the microtubule-associated serine/threonine kinase (MAST) family, plays a crucial role in regulating cellular processes such as cytoskeletal dynamics, cell migration, and cell cycle progression. MAST4 is primarily localized to the cytoplasm and is known to interact with various cytoskeletal proteins, including microtubules and actin filaments, thereby influencing their organization and dynamics. Additionally, MAST4 has been implicated in the regulation of cell polarity and cell adhesion, suggesting its involvement in fundamental cellular processes critical for tissue morphogenesis and homeostasis. Furthermore, studies have suggested links between MAST4 dysregulation and various pathological conditions, including cancer and neurological disorders, highlighting its importance as a target.
Inhibition of MAST4 activity represents a promising strategy for modulating cellular processes associated with its function. Various mechanisms have been proposed for inhibiting MAST4, including small molecule inhibitors targeting its catalytic domain or allosteric sites. Additionally, RNA interference-based approaches have been explored to silence MAST4 expression, thereby attenuating its activity. Furthermore, competitive inhibitors that disrupt protein-protein interactions involving MAST4 and its binding partners have shown efficacy in studies. Understanding the precise structural and functional characteristics of MAST4 and its regulatory mechanisms is crucial for the rational design of effective inhibitors. Overall, elucidating the mechanisms of MAST4 inhibition holds promise for uncovering novel avenues for diseases associated with its dysregulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor that can inhibit MAST4 by targeting its kinase domain, leading to the cessation of its kinase activity. | ||||||
K-252a | 99533-80-9 | sc-200517 sc-200517B sc-200517A | 100 µg 500 µg 1 mg | $129.00 $214.00 $498.00 | 19 | |
K252a is a broad-spectrum kinase inhibitor, similar to staurosporine, that can inhibit MAST4 by targeting its kinase activity. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
Sunitinib is a multi-targeted receptor tyrosine kinase (RTK) inhibitor. Since MAST4 is a kinase, sunitinib can inhibit its kinase activity, which is crucial for its functional activity. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine is an AKT inhibitor. MAST4, being a kinase, may be involved in the PI3K/AKT signaling pathway; thus, triciribine can lead to decreased MAST4 activity by inhibiting this pathway. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a multi-kinase inhibitor. It can inhibit MAST4 by targeting its kinase activity, leading to the cessation of its function. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Lapatinib is a dual tyrosine kinase inhibitor that inhibits both EGFR and HER2/neu. As MAST4 is a kinase, lapatinib can inhibit its kinase activity, decreasing its functional activity. | ||||||
AZD8055 | 1009298-09-2 | sc-364424 sc-364424A | 10 mg 50 mg | $163.00 $352.00 | 12 | |
AZD8055 is a specific mTOR inhibitor. If MAST4 is involved in mTOR signaling, AZD8055 can lead to decreased MAST4 activity by inhibiting this pathway. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $209.00 $413.00 | 9 | |
Nilotinib is a tyrosine kinase inhibitor. It can inhibit MAST4 by targeting its kinase activity, which is crucial for its functional activity. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a multi-kinase inhibitor. It can inhibit MAST4 by targeting its kinase activity, leading to the cessation of its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. If MAST4 is involved in the JNK signaling pathway, SP600125 can decrease its activity. | ||||||